A Retrospective Evaluation of Efficacy and Tolerability of Two Different Adjuvant Chemoradiotherapy Regimens in Operable Node-Positive Gastric Carcinoma with D2 Lymph Node Dissection

Aim: Optimal adjuvant treatment in gastric cancer (GC) patients ( pts) with D2 lymph node dissection (D2LND) is still undefined.The aim of this retrospective study was to evaluate the efficacy and tolerability of two different adjuvant chemoradiotherapy (ACRT) regimens in operable node-positive GC pts with D2LND.Methods: 138 curatively resected GC pts who underwent D2LND and had node-positive disease were included in this study.They